UNSPSC 51101671: Phanquinone or phanquone

This classification denotes a topical anti-infective agent and antiprotozoal agent with the molecular formula C12H6N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ID94IS6N8J, chemically known as 4,7-phenanthroline-5,6-quinone but generally known as phanquinone, which bears US NIH Compound Identifier 6764. European Medicines Agency schedules Phanquinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09742MIG.

UNSPSC 51101671 Phanquinone or phanquone is a Commodity code that in practice covers pharmaceuticals and medical supplies—including naloxone, generic multi-source drugs, and emergency medical consumables—purchased by state health agencies, counties, cities, and fire departments for public health and emergency response. State and local governments buy these products through competitive sealed-bid processes, cooperative purchasing vehicles, and requests for information to support community health initiatives, pharmacy benefit programs, and first-responder operations. Issuing bodies span state health and human services commissions, county health departments, municipal fire departments, and multistate cooperative purchasing alliances. Recent solicitations show health agencies and local jurisdictions procuring both branded emergency pharmaceuticals (naloxone for opioid response) and commodity generic drugs and OTC products in volume through authorized wholesale distributors.

The code shows activity concentrated in Florida, Minnesota, Texas, and across the multistate cooperative network. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023, on a two-year term with one-year renewal option. The City of Tampa's Purchasing Department posted ITB 26P00145 in March 2026 for 169 line items of medical and first-aid supplies for the Fire Department Rescue Division, with an estimated contract value of $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount not to exceed $10,000. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 to establish multiple contracts for generic pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with proposals due March 26, 2026, effective July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program.